Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors

Abstract

Monoamine oxidases (MAOs) are flavo-enzymes that aid in the oxidative deamination of neurotransmitters like dopamine, serotonin, and epinephrine. MAO inhibitors are antidepressants that work by preventing the breakdown of brain neurotransmitters and regulating mood. MAO inhibitors that use the chromone (1-benzopyran-4-one) structure have been found to be quite effective in studies. The current study involves the creation of pharmacophore models, 3-D QSAR, virtual screening, and docking investigations, all of which are evaluated using various criteria. The investigation included 39 ligands that emerged pharmacophore AHRRR_1, as the best pharmacophore model with a survival score of 5.6485. The 3D QSAR investigation revealed a significant model with the values of R² = 0.9064 and Q² = 0.8239. Docking study revealed that compound 18 had the highest docking (−10.402 kcal/mol) score in the series and showed interactions with the essential amino acid TYR398 required for MAO inhibitory activity. ZINC compounds were screened using the created pharmacophore model, which was followed up with a virtual screening study. The ZINC compounds with the best XP docking scores are ZINC03113255, ZINC07777127, ZINC05166353 and ZINC09341502 (with docking scores −10.021, −9.486, −8.031 and −7.792 kcal/mol, respectively). ZINC03113255, which showed the best score, has binding interactions with amino acid residues, TYR326, TYR398 and LYS296 of monoamine oxidase B. The ADME analysis demonstrated the compound’s drug-like characteristics. The findings of this study may be used in the development of chromone compounds that target the MAO inhibitor.

Communicated by Ramaswamy H. Sarma

Keywords:

• Chromone derivative
• MAO inhibitors
• pharmacophore model
• zinc compounds
• atom-based model
• field-based model

Acknowledgments

Dr Abuzer Ali is thankful to Taif University Researchers Supporting Project Number (TURSP2020/124), Taif University, Taif, Saudi Arabia.

Disclosure statement

The authors declare no conflict of interest